AJP - Heart Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (February 15, 2008). doi:10.1152/ajpheart.01281.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/H1685    most recent
01281.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Guilder, G. P
Right arrow Articles by DeSouza, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Guilder, G. P
Right arrow Articles by DeSouza, C. A.
Submitted on November 1, 2007
Accepted on February 13, 2008

IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION IN OVERWEIGHT AND OBESE ADULT HUMANS IS NOT LIMITED TO MUSCARINIC RECEPTOR AGONISTS

Gary P Van Guilder1, Brian L Stauffer2, Jared J. Greiner3, and Christopher A. DeSouza4*

1 United States; Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States
2 Medicine, UCHSC, 80262, Colorado, United States
3 Integrative Physiology, University of Colorado, Boulder, Colorado, United States; , United States
4 Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States

* To whom correspondence should be addressed. E-mail: desouzac{at}colorado.edu.

Muscarinic receptor agonists have primarily been used to characterize endothelium-dependent vasodilator dysfunction with overweight/obesity. Reliance on a single class of agonist however, yields limited, and potentially misleading, information regarding endothelial vasodilator capacity. The aims of this study were to determine: 1) if the overweight/obesity-related reduction in endothelium-dependent vasodilation extends beyond muscarinic receptor agonists; and 2) the contribution of nitric oxide to endothelium-dependent vasodilation is reduced in overweight/obese adults. Eighty-six middle-aged and older adults were studied: 42 normal weight (age 54±1 yr; 21 M/21 F; BMI 23.4±0.3 kg/m2) and 44 overweight/obese (54±1 yr; 28 M/16 F; 30.3±0.6 kg/m2). Forearm blood flow (FBF) responses to intra-arterial infusions of acetylcholine in the absence and presence of the endothelial nitric oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA), methacholine, bradykinin, substance P, isoproterenol and sodium nitroprusside were measured by strain-gauge plethysmography. FBF responses to each endothelial agonist were significantly blunted in the overweight/obese adults. Total FBF (area under the curve) to acetylcholine (50±5 vs 79±4 mL/100 mL tissue), methacholine (55±4 vs 86±5), bradykinin (62±5 vs 85±4 mL/100 mL tissue), substance P (37±4 vs 57±5 mL/100 mL tissue) and isoproterenol (62±4 vs 82±6 mL/100 mL tissue) were 30%-40% lower in the overweight/obese vs normal weight adults. L-NMMA significantly reduced the FBF response to acetylcholine to the same extent in both groups. There were no differences between the groups in the FBF responses to SNP. These results indicate that agonist-stimulated endothelium-dependent vasodilation is universally impaired with overweight/obesity. Moreover, this impairment appears to be independent of nitric oxide.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.